OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Submission Deadline: January 30, 2024 (Open) Submit Now
Ashwini Arjuna, MD
Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA
Research Interests: Lung transplantation; Advanced pulmonary disease; Pulmonary hypertension; Antibody mediated rejection; COVID and lung transplant
About This Topic
From the era of early experimental lung transplant strategies to successful lung implantation for various advanced lung diseases with improved survival and quality of life, the science of surgical and medical management of lung transplantation has evolved significantly. The growing gap between a high demand and a limited supply of these valuable organs has made us expand the donor pool with strategies including Ex Vivo Lung Perfusion (EVLP), donation after cardiac death (DCD donation), Hepatitis C donor pool, innovative ventilator mechanisms to help salvage more organs to be viable for donation, to name a few. Despite this exponential growth, chronic rejection in the forms of restrictive allograft dysfunction, bronchiolitis obliterans syndrome, antibody mediated rejection , remains the most dreadful limiting factor for long term outcomes after transplantation thus prompting ongoing research and scientific work. The COVID pandemic has added another layer complexity further letting us push the boundaries of lung transplantation.
The Special Issue in Lung Transplantation will provide a platform for ongoing research, studies and investigations to come to the limelight from professionals involved in this niche area of interest.
Manuscript Submission Information
Manuscripts should be submitted online at http://www.lidsen.com/Passport/Index/login by registering and logging in to this website. Once registered and activated, please click here to go to the submission form. A guide for authors and other relevant information for submission of manuscripts is available on Instructions for Authors.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are highly invited. For planned papers, a tentative title and short abstract (about 100 words) can be sent to the Editorial Office (firstname.lastname@example.org) for record. Welcome your submission!
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.